News

AnaptysBio to Attend Key Investor Conferences in September

AnaptysBio to Attend Key Investor Conferences in September

AnaptysBio to Attend Key Investor Conferences in September

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company dedicated to advancing innovative immunology therapeutics, has announced its participation in several important investor conferences this September. The company's president and CEO, Daniel Faga, along with other senior management team members, will represent AnaptysBio at these events, showcasing their commitment to engaging with investors.

2024 Wells Fargo Healthcare Conference

One of the key events is the 2024 Wells Fargo Healthcare Conference, which will be held in Boston. This conference will include a fireside chat and opportunities for one-on-one meetings with investors.

Details of the Conference

The conference is scheduled for September 5th at 10:15 AM ET / 7:15 AM PT. This format provides investors with a valuable chance to hear directly from the company’s leaders about the latest developments at AnaptysBio.

Stifel 2024 Virtual Immunology and Inflammation Summit

After the Wells Fargo event, AnaptysBio will also take part in the Stifel 2024 Virtual Immunology and Inflammation Summit.

Event Overview

This summit is set for September 17th, starting at 1:30 PM ET / 10:30 AM PT. It will feature a fireside chat, allowing participants to gain insights into the latest advancements in immunology and inflammation treatments from leading experts.

2024 Cantor Fitzgerald Global Healthcare Conference

Another significant event on AnaptysBio's agenda is the 2024 Cantor Fitzgerald Global Healthcare Conference, which will take place in New York.

Highlights of the Conference

This conference is scheduled for September 18th at 9:45 AM ET / 6:45 AM PT. It will follow a similar format, including a fireside chat and one-on-one investor meetings, providing an excellent platform for the company to discuss its innovative therapeutic approaches.

Webcast Information

For those who cannot attend in person, live webcasts of the fireside chats will be available on the investor section of the AnaptysBio website. Replays of these webcasts will be accessible for at least 30 days after the events, ensuring that investors can stay updated on the company's activities.

About AnaptysBio

AnaptysBio is making strides in the biotechnology sector with its focus on immunology therapeutics. The company is actively developing immune cell modulators aimed at treating autoimmune and inflammatory diseases. Among its key candidates are two checkpoint agonists: ANB032, a BTLA agonist currently in a Phase 2b trial for atopic dermatitis, and rosnilimab, a PD-1 agonist, which is undergoing a Phase 2b trial for rheumatoid arthritis and a Phase 2 trial for ulcerative colitis.

Pipeline Overview

In addition to these programs, AnaptysBio has several promising candidates in its pipeline, including ANB033, an anti-CD122 antagonist antibody that is entering a Phase 1 trial, and ANB101, a BDCA2 modulator antibody currently in preclinical development. The company has also developed two cytokine antagonists available for out-licensing: imsidolimab, which has completed Phase 3 trials for generalized pustular psoriasis, and etokimab, which is ready for Phase 2/3 trials.

Collaborative Efforts

AnaptysBio has successfully partnered with GSK to develop various therapeutic antibodies targeting immuno-oncology, including an anti-PD-1 antagonist antibody known as Jemperli (dostarlimab-gxly) and an anti-TIM-3 antagonist antibody (cobolimab, GSK4069889). This collaboration underscores the company’s innovative approach and dedication to advancing treatments in the immuno-oncology field.

Contact Information

For more information about AnaptysBio, investors and interested parties can reach out to:

Nick Montemarano
Senior Director, Investor Relations and Strategic Communications
858.732.0178
Email: investors@anaptysbio.com

Frequently Asked Questions

What is AnaptysBio focused on?

AnaptysBio is dedicated to developing innovative immunology therapeutics aimed at treating autoimmune and inflammatory diseases.

What events is AnaptysBio participating in September?

The company will participate in the 2024 Wells Fargo Healthcare Conference, the Stifel 2024 Virtual Immunology Summit, and the 2024 Cantor Fitzgerald Global Healthcare Conference.

What are some key products in AnaptysBio's pipeline?

Key products include ANB032 and rosnilimab, both of which are currently in clinical trials for various conditions.

How can investors follow AnaptysBio's events?

Investors can follow the events through live webcasts available on the AnaptysBio investor website.

Who should be contacted for investor relations?

For inquiries related to investor communications, Nick Montemarano, Senior Director of Investor Relations, can be contacted.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 21

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 25

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 9

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 18

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 23

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 22

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 14

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 15

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading

Top 5 Most Recently Viewed Articles

Tonal 2 Revolutionizes Home Fitness with Innovative Design

Updated Category News Views 762

Tonal 2 Revolutionizes Home Fitness Experience Tonal, recognized for pioneering the world’s most intelligent strength training system, is thrilled to introduce Tonal 2. This innovative home fitness solution is meticulously designed to enhance performance and expedite muscle building. Outfitted with a stunning all-black finish and chic chrome accents, Tonal 2 not only...

Continue Reading
Innovative MEMS Probe Card Enhances Semiconductor Testing

Updated Category News Views 214

Transforming Semiconductor Testing with MEMS Technology STAr Technologies, a prominent name in the probe card manufacturing landscape, has recently introduced its latest innovation, the STAr Virgo Prima. This advanced probe card not only exemplifies 25 years of expertise but also represents a significant leap forward in the realm of semiconductor testing. Designed...

Continue Reading
Wyndham Hotels & Resorts Earnings Call Announcement and Insights

Updated Category News Views 180

Wyndham Hotels & Resorts to Report Second Quarter Earnings Wyndham Hotels & Resorts (NYSE: WH) is set to announce its second quarter results, promising insights into their performance and future strategies. This announcement is of particular interest to investors and travelers alike, as it underscores the company's significant role in the global hospitality industry....

Continue Reading
Strategic Leadership Changes at Hankook Tire Boost Growth

Updated Category News Views 376

Strategic Leadership Changes at Hankook Tire Boost Growth Hankook Tire & Technology, a leading tire manufacturer, has recently announced several key executive leadership updates within its North American sales and marketing team. These changes are designed to strengthen their operations and ensure the company's growth trajectory continues in the competitive tire market....

Continue Reading
Senate Hearing on Semiconductor Use in Russian Military

Updated Category News Views 49

Senate Panel to Discuss Semiconductor Manufacturers The U.S. Senate Permanent Subcommittee on Investigations is preparing for an important hearing that will examine the role of American semiconductor companies in relation to Russian military applications. This hearing is a direct response to discoveries that American-made semiconductors have been found in weapons...

Continue Reading